Lycopene for prevention and treatment of prostate cancer

American Journal of Health-System Pharmacy

Volumn 61, Issue 15, 2004, Pages

  Everson, Kaia M ^a   McQueen, Cydney E ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA TOCOPHEROL; ANTIANDROGEN; BETA CAROTENE; CANTHAXANTHIN; CAROTENOID; LEUPRORELIN; LYC-O-MATO; LYCOPENE; NICOTINE; PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN; VITAMIN D; XANTHOPHYLL; ANTINEOPLASTIC AGENT;

ANTIOXIDANT ACTIVITY; CANCER PREVENTION; CANCER RISK; CLINICAL FEATURE; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG FORMULATION; DRUG STRUCTURE; DRUG USE; EATING HABIT; EXERCISE INDUCED ASTHMA; FOOD COMPOSITION; FOOD INTAKE; HUMAN; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK FACTOR; RISK REDUCTION; SABAL; TREATMENT OUTCOME; BIOAVAILABILITY; CLINICAL TRIAL; DRUG INTERACTION; MALE; PROSTATE TUMOR; TOMATO;

ANTICARCINOGENIC AGENTS; BIOLOGICAL AVAILABILITY; CAROTENOIDS; CLINICAL TRIALS; DRUG INTERACTIONS; HUMANS; LYCOPERSICON ESCULENTUM; MALE; PROSTATIC NEOPLASMS;

EID: 7744239595     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.15.1562     Document Type: Review

References (19)

1. American Cancer Society. Cancer facts and figures 2002. www.cancer.org/docroot/STT/stt_0_2002.asp?sitearea=STT&level=1 (accessed 2003 Sep 25).
2. Hadley CW, Miller EC, Schwartz SJ et al. Tomatoes, lycopene, and prostate cancer: progress and promise. Exp Biol Med (Maywood). 2002; 227:869-80.
3. Boyle P, Severi G, Graham G. The epidemiology of prostate cancer. Urol Clin North Am. 2003; 30:208-17.
4. Dipiro JT, Talbert RL, Yee GC et al., eds. Pharmacotherapy: a pathophysiologic approach. 5th ed. New York: McGraw-Hill; 2002:2313-29.
5. Natural Medicines Comprehensive Database. www.naturaldatabase.com (accessed 2003 Sep).
6. Giovannucci E. A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Exp Biol Med (Maywood). 2002; 227:852-9.
7. Boileau TW, Boileau AC, Erdman JW Jr. Bioavailability of all-trans and cis-isomers of lycopene. Exp Biol Med (Maywood). 2002; 227:914-9.
8. Basch E, Ulbricht C, eds. Natural standard. www.naturalstandard.com (accessed 2003 Sep).
9. Marchand LL, Hankin JH, Kolonel LN et al. Vegetable and fruit consumption in relation to prostate cancer risk in Hawaii: a reevaluation of the effect of dietary beta-carotene. Am J Epidemiol. 1991; 133:215-9.
10. Giovannucci E, Ascherio A, Rimm EB et al. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst. 1995; 87:1767-76.
11. Kucuk O, Sarkar FH, Sakr W et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev. 2001; 10:861-8.
12. Lyc-o-mato. www.lycored.com/Lyc-O-Mato.cfm (accessed 2003 Aug 26).
13. Kucuk O, Sarkar FH, Djuric ZS et al. Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med (Maywood). 2002; 227:881-5.
14. Ansari MS, Gupta NP. A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer. BJU Int. 2003; 92:375-8.
15. Matlaga BR, Hall MC, Stindt D et al. Response of hormone refractory prostate cancer to lycopene. J Urol. 2001; 166:613.
16. Carraro JC, Raynaud JP, Koch G et al. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. Prostate. 1996; 29:231-40.
17. Michaud DS, Feskanich D, Rimm EB et al. Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. Am J Clin Nutr. 2000; 72:990-7.
18. Neuman I, Ben-Amotz A. Reduction of exercise-induced asthma oxidative stress by lycopene, a natural antioxidant. Allergy. 2000; 55:1184-9.
19. Lu QY, Hung JC, Heber D et al. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2001; 10:749-56.